Financials data is unavailable for this security.
View more
Year on year Willow Biosciences Inc grew revenues 42.75% from 821.00k to 1.17m while net income improved from a loss of 14.81m to a smaller loss of 13.03m.
| Gross margin | -- |
|---|---|
| Net profit margin | -472.83% |
| Operating margin | -458.42% |
| Return on assets | -117.73% |
|---|---|
| Return on equity | -212.20% |
| Return on investment | -164.04% |
More ▼
Cash flow in CADView more
In 2023, cash reserves at Willow Biosciences Inc fell by 7.86m. However, Cash Flow from Investing totalled 3.47m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 10.92m for operations while cash used for financing totalled 318.00k.
| Cash flow per share | -0.0563 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -0.0004 |
|---|---|
| Tangible book value per share | -0.0004 |
More ▼
Balance sheet in CADView more
| Current ratio | 0.7005 |
|---|---|
| Quick ratio | 0.6479 |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | 1.03 |
More ▼
